Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KDM5 histone demethylases repress immune response via suppression of STING
Lizhen Wu, Jian Cao, Wesley L. Cai, et al.
PLoS Biology (2018) Vol. 16, Iss. 8, pp. e2006134-e2006134
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19
Bruna G.G. Pinto, Antônio Edson Rocha Oliveira, Youvika Singh, et al.
The Journal of Infectious Diseases (2020) Vol. 222, Iss. 4, pp. 556-563
Open Access | Times Cited: 358
The language of chromatin modification in human cancers
Shuai Zhao, C. David Allis, Gang Greg Wang
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 413-430
Open Access | Times Cited: 297
STING pathway agonism as a cancer therapeutic
Blake Flood, Emily F. Higgs, Shuyin Li, et al.
Immunological Reviews (2019) Vol. 290, Iss. 1, pp. 24-38
Open Access | Times Cited: 270
Cancer Epigenetics, Tumor Immunity, and Immunotherapy
Jian Cao, Qin Yan
Trends in cancer (2020) Vol. 6, Iss. 7, pp. 580-592
Open Access | Times Cited: 255
Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response
Dongshan Wan, Wei Jiang, Junwei Hao
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 213
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 196
Histone H3 lysine K4 methylation and its role in learning and memory
Bridget E. Collins, Celeste B. Greer, Benjamin C. Coleman, et al.
Epigenetics & Chromatin (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 155
The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation
James Scarth, Molly R. Patterson, Ethan L. Morgan, et al.
Journal of General Virology (2021) Vol. 102, Iss. 3
Open Access | Times Cited: 154
Endogenous Retroelements and the Viral Mimicry Response in Cancer Therapy and Cellular Homeostasis
Raymond Chen, Charles A. Ishak, Daniel D. De Carvalho
Cancer Discovery (2021) Vol. 11, Iss. 11, pp. 2707-2725
Open Access | Times Cited: 131
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Zhenyi Niu, Runsen Jin, Yan Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 96
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression
Meiling Zhang, Zongzhi Liu, Keisuke Aoshima, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 630
Open Access | Times Cited: 92
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Martina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Immunology (2022) Vol. 23, Iss. 9, pp. 1379-1392
Open Access | Times Cited: 79
The balance of STING signaling orchestrates immunity in cancer
Klara Rasmussen Bollerup Lanng, Emil Leth Lauridsen, Martin R. Jakobsen
Nature Immunology (2024) Vol. 25, Iss. 7, pp. 1144-1157
Closed Access | Times Cited: 45
Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer
Victor C. Kok
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 92
The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis
Om Basukala, Lawrence Banks
Viruses (2021) Vol. 13, Iss. 10, pp. 1892-1892
Open Access | Times Cited: 89
ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19
Bruna G.G. Pinto, Antônio Edson Rocha Oliveira, Youvika Singh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 78
MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer
Siyu Wu, Yi Xiao, Jinli Wei, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002528-e002528
Open Access | Times Cited: 69
Mechanisms of COVID-19 pathogenesis in diabetes
Chandrakala Aluganti Narasimhulu, Dinender K. Singla
AJP Heart and Circulatory Physiology (2022) Vol. 323, Iss. 3, pp. H403-H420
Open Access | Times Cited: 43
Histone demethylases in the regulation of immunity and inflammation
Lihua Qu, Tong Yin, Yijin Zhao, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 30
High‐risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects
Irene Lo Cigno, Federica Calati, Carlo Girone, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 6
Open Access | Times Cited: 15
Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications
Jun Yin, Tiezheng Gu, Norin Chaudhry, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 11
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
Changyun Li, Wanhe Wang, Chung‐Hang Leung, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Management approaches for recurrent or metastatic head and neck squamous cell carcinoma after anti-PD-1/PD-L1 immunotherapy
Makoto Tahara, Wan‐Teck Lim, Bhumsuk Keam, et al.
Cancer Treatment Reviews (2025), pp. 102938-102938
Closed Access | Times Cited: 1
Subversion of Host Innate Immunity by Human Papillomavirus Oncoproteins
Irene Lo Cigno, Federica Calati, Silvia Albertini, et al.
Pathogens (2020) Vol. 9, Iss. 4, pp. 292-292
Open Access | Times Cited: 54
Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition
Lin Xia, Zaozao Zheng, Junyi Liu, et al.
Cancer Immunology Research (2021) Vol. 9, Iss. 6, pp. 707-722
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top